| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert G. Spignesi Jr. | PRESIDENT AND CEO | 2026-02-09 | 12,840 | $3.78 | $48.57kSell |
| Sean M. Wirtjes | CHIEF FINANCIAL OFFICER | 2026-02-09 | 6,027 | $3.78 | $22.80kSell |
| John J. Addington Wilson | CHIEF OPERATING OFFICER | 2026-02-09 | 4,610 | $3.78 | $17.44kSell |
| Longitude Capital Partners II LLC | 10% Owner | 2026-02-04 | 49,000 | $3.88 | $190.07kSell |
| Longitude Capital Partners II LLC | 10% Owner | 2026-02-03 | 27,500 | $4.24 | $116.66kSell |
| Longitude Capital Partners II LLC | 10% Owner | 2026-02-02 | 27,500 | $4.25 | $116.77kSell |
| Longitude Capital Partners II LLC | 10% Owner | 2026-01-30 | 46,000 | $4.54 | $208.98kSell |
| Longitude Capital Partners II LLC | 10% Owner | 2026-01-23 | 629,032 | $0.05 | $31.45kBuy |
| Longitude Capital Partners II LLC | 10% Owner | 2026-01-23 | 7,739 | $4.06 | $31.45kSell |
| Robert G. Spignesi Jr. | PRESIDENT AND CEO | 2025-10-17 | 4,774 | $3.08 | $14.70kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jeffrey Lawrence Schwartz | 19.06% | 8,448,860 | $34.47M | Insider |
| Bain Capital Life Sciences Investors LLC | 19.03% | 8,434,560 | $34.41M | Insider |
| Bain Capital Life Sciences Investors LLC | 19.03% | 8,434,560 | $34.41M | Institution |
| Longitude Capital Partners II LLC | 9.23% | 4,093,159 | $16.70M | Insider |
| David Hirsch | 7.72% | 3,422,252 | $13.96M | Insider |
| Kennedy Lewis Management LP | 6.55% | 2,904,490 | $11.85M | Insider |
| Abgwtt Global Life Science Capital Partners GP Ltd | 4.17% | 1,848,296 | $7.54M | Institution |
| Richard S. Kollender | 3.59% | 1,592,027 | $6.50M | Insider |
| Vanguard Group Inc | 2.18% | 965,018 | $3.94M | Institution |
| Robert G. Spignesi Jr. | 2.17% | 962,097 | $3.93M | Insider |